CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NASDAQ: ZOLL), a manufacturer of resuscitation devices and related software solutions, today announced that its Board of Directors had approved a 2-for-1 stock split. The stock split, which is scheduled to become effective on February 12, 2007, will be accomplished through an amendment to ZOLL’s Restated Articles of Organization that changes each issued and authorized share of Common Stock, par value $0.02 per share, into two shares of Common Stock, par value $0.01 per share.
